Are Elanco Animal Health Incorporated's (NYSE:ELAN) Mixed Financials Driving The Negative Sentiment?
Elanco Animal Health (NYSE:ELAN) Investors Are Sitting on a Loss of 60% If They Invested Five Years Ago
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
S&P 500 Futures Rise In Premarket Trading; Bausch + Lomb, Bio-Techne Lag
Elanco Animal Health Poised for 'Accelerating' EBITDA Growth in 2026 Despite Zenrelia Concerns, UBS Says
Express News | Elanco Animal Health Shares up 2.3% Premarket After UBS Initiates Coverage With Buy Rating
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Elanco Animal Health Price Target Announced at $18.00/Share by UBS
UBS Initiates Elanco Animal Health(ELAN.US) With Buy Rating, Announces Target Price $18
Little Excitement Around Elanco Animal Health Incorporated's (NYSE:ELAN) Revenues
Daily short sale tracking: Palantir's short volume increased by 5 million, with a short sale ratio of 11%
Top 3 Health Care Stocks That Could Blast Off In December
Unusual Options Activity: PINS, MCHP and Others Attract Market Bets, PINS V/OI Ratio Reaches 333.3
Elanco Animal Health Analyst Ratings
Leerink Partners Initiates Elanco Animal Health(ELAN.US) With Hold Rating, Announces Target Price $14
Express News | Elanco Animal Health Inc : Leerink Partners Initiates Coverage With Market Perform Rating; Price Target $14
Elanco Animal Health Incorporated (ELAN): An Oversold Healthcare Stock to Invest In Now
Oppenheimer's Top Buy and Sell Ideas From Each of the Sectors
Elanco to Participate in the Upcoming Investor Conferences